Skip to main content

Animations

MJFF Publications

6211 - 6220 of 9131 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2015
  • 2022
  • 2021
  • 2018
  • 2016
  • 2025
  • 2019
  • 2021
  • Summary Details
    OPEN
    Title: Remote Digital Monitoring for Medical Product Development
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cts.12851
    Citation Count: 22
  • Summary Details
    OPEN
    Title: The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.12915
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial Finder
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-140522
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Putting participants and study partners FIRST when clinical trials end early
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12732
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s Disease
    Journal Name: MDM Policy & Practice
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/23814683211021380
    Citation Count: 14
  • Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    2018
    Summary Details
    RESTRICTED
    Title: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27392
    Citation Count: 165
  • Summary Details
    OPEN
    Title: Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1096/fj.201600756r
    Citation Count: 409
  • Promise and Challenge of β-Lactone Electrophiles to Target Aspartate 12 of Mutant KRASG12D
    2025
    Summary Details
    RESTRICTED
    Title: Promise and Challenge of β-Lactone Electrophiles to Target Aspartate 12 of Mutant KRASG12D
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5c01214
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2019.101824
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.